SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 0.28 |
Enterprise Value ($M) | -3.63 |
Book Value ($M) | 3.36 |
Book Value / Share | 2.96 |
Price / Book | 0.08 |
NCAV ($M) | 3.36 |
NCAV / Share | 2.96 |
Price / NCAV | 0.08 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.27 |
Return on Assets (ROA) | -0.80 |
Return on Equity (ROE) | -1.10 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.41 |
Current Ratio | 2.41 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 5.74 |
Assets | 5.74 |
Liabilities | 2.38 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -9.52 |
Net Income | -8.63 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -8.56 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Terker Bruce E | 0.00 | -100.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
8,488 | 46,877 | 18.11 | |
3,781 | 32,446 | 11.65 | |
(click for more detail) |